Daniela Damiani

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 23

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Tyrosine Kinase

Top Venues

International journal of molecular sciences

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Daniela Damiani, Mario Tiribelli
CAR-T Cells in Acute Myeloid Leukemia: Where Do We Stand? Biomedicines 12 (6) (2024)
Daniela Damiani, Mario Tiribelli
ATP-Binding Cassette Subfamily G Member 2 in Acute Myeloid Leukemia: A New Molecular Target? Biomedicines 12 (1) (2024)
Daniela Damiani, Mario Tiribelli
CAR-T Cells in Acute Myeloid Leukemia: Where Do We Stand? Biomedicines 12 (6) (2024)
Daniela Damiani, Mario Tiribelli
ATP-Binding Cassette Subfamily G Member 2 in Acute Myeloid Leukemia: A New Molecular Target? Biomedicines 12 (1) (2024)
Daniela Damiani, Mario Tiribelli
ABCG2 in Acute Myeloid Leukemia: Old and New Perspectives. International journal of molecular sciences 24 (8) (2023)
Daniela Damiani, Mario Tiribelli
ABCG2 in Acute Myeloid Leukemia: Old and New Perspectives. International journal of molecular sciences 24 (8) (2023)
Daniela Damiani, Mario Tiribelli
ABCG2 in Acute Myeloid Leukemia: Old and New Perspectives. International journal of molecular sciences 24 (8) (2023)
Daniela Damiani, Mario Tiribelli
Checkpoint Inhibitors in Acute Myeloid Leukemia. Biomedicines 11 (6) (2023)
Daniela Damiani, Mario Tiribelli
Checkpoint Inhibitors in Acute Myeloid Leukemia. Biomedicines 11 (6) (2023)
Daniela Damiani, Mario Tiribelli
ABCG2 in Acute Myeloid Leukemia: Old and New Perspectives. International journal of molecular sciences 24 (8) (2023)
Daniela Damiani, Mario Tiribelli
Present and Future Role of Immune Targets in Acute Myeloid Leukemia. Cancers 15 (1) (2022)
Mario Tiribelli, Eleonora Toffoletti, Sara Di Giusto, Renato Fanin, Daniela Damiani
Optimal timing of molecular monitoring after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia. European journal of haematology (2022)
Sara Di Giusto, Eleonora Toffoletti, Massimiliano Bonifacio, Gianni Binotto, Maria Cristina Miggiano, Elisabetta Calistri, Manuela Stulle, Anna Ermacora, Rossella Stella, Luigi Scaffidi, Fabio D'Amore, Giorgia Scotton, Davide Griguolo, Giovanna De Matteis, Roberta Bertorelle, Mauro Krampera, Gianpietro Semenzato, Renato Fanin, Daniela Damiani, Mario Tiribelli
BCR::ABL1 levels at first month after TKI discontinuation predict subsequent maintenance of treatment-free remission: A study from the "GRUPPO TRIVENETO LMC". Cancer medicine (2022)
Daniela Damiani, Mario Tiribelli
Present and Future Role of Immune Targets in Acute Myeloid Leukemia. Cancers 15 (1) (2022)
Daniela Damiani, Mario Tiribelli
Present and Future Role of Immune Targets in Acute Myeloid Leukemia. Cancers 15 (1) (2022)
Mario Tiribelli, Alessandra Sperotto, Francesca Patriarca, Daniela Damiani, Renato Fanin
Haploidentical transplant after failure of a first allogeneic transplant: A long and winding road. European journal of haematology 106 (6) (2021)
Mario Tiribelli, Angela Michelutti, Margherita Cavallin, Sara Di Giusto, Erica Simeone, Renato Fanin, Daniela Damiani
BCL-2 Expression in AML Patients over 65 Years: Impact on Outcomes across Different Therapeutic Strategies. Journal of clinical medicine 10 (21) (2021)
Mario Tiribelli, Angela Michelutti, Margherita Cavallin, Sara Di Giusto, Renato Fanin, Daniela Damiani
Impact of Concomitant Aberrant CD200 and BCL2 Overexpression on Outcome of Acute Myeloid Leukemia: A Cohort Study from a Single Center Turkish journal of haematology : official journal of Turkish Society of Haematology 38 (2) (2021)
Massimiliano Bonifacio, Mario Tiribelli, Maria Cristina Miggiano, Elisabetta Abruzzese, Gianni Binotto, Luigi Scaffidi, Maddalena Cordioli, Daniela Damiani, Eros Di Bona, Malgorzata Monika Trawinska, Ilaria Tanasi, Maria Vittoria Dubbini, Vanessa Velotta, Giulia Ceccarelli, Elisabetta Pierdomenico, Mariella Lo Schirico, Gianpietro Semenzato, Marco Ruggeri, Renato Fanin, Evelina Tacconelli, Giovanni Pizzolo, Mauro Krampera
The serological prevalence of SARS-CoV-2 infection in patients with chronic myeloid leukemia is similar to that in the general population. Cancer medicine 10 (18) (2021)
Haifa Kathrin Al-Ali, Martin Griesshammer, Lynda Foltz, Giuseppe A Palumbo, Bruno Martino, Francesca Palandri, Anna Marina Liberati, Philipp le Coutre, Carmen García-Hernández, Andrey Zaritskey, Renato Tavares, Vikas Gupta, Pia Raanani, Pilar Giraldo, Mathias Hänel, Daniela Damiani, Tomasz Sacha, Catherine Bouard, Carole Paley, Ranjan Tiwari, Francesco Mannelli, Alessandro M Vannucchi
Primary analysis of JUMP, a phase 3b, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts. British journal of haematology 189 (5) (2020)
Mario Tiribelli, Angela Michelutti, Renato Fanin, Daniela Damiani
ABCG2 overexpression and deoxyadenosine analogue activity in acute myeloid leukemia. Cancer 123 (24) (2017)
Mario Tiribelli, Antonella Geromin, Margherita Cavallin, Sara Di Giusto, Erica Simeone, Renato Fanin, Daniela Damiani
ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AML. European journal of haematology 99 (3) (2017)
Mario Tiribelli, Antonella Geromin, Daniela Damiani
Impact of fludarabine-based induction therapy on outcome of FLT3-/NPM1+ cytogenetically normal acute myeloid leukemia. American journal of hematology 92 (4) (2017)